Skip to content

Category Archives: Evidence Base

Links to articles from across the net on the ever developing evidence base.

Top priorities for alcohol regulators in the United States: protecting public health or the alcohol industry?

ABSTRACT Aims  This paper describes alcohol industry involvement in the 2010 annual conference proceedings of the National Conference of State Liquor Administrators (NCSLA) in the United States. Design  The author attended the conference, observed conference attendees and panelists and identified key themes in the panel sessions. Setting  The NCSLA Annual Meeting took place 20–24 June 2010 in New Orleans, Louisiana

Commentary on Baker et al. (2012): Assessing dependence—are specific criteria for nicotine enough or do we need to consider its forms of…

%excerpt%
Continue reading here:
Commentary on Baker et al. (2012): Assessing dependence—are specific criteria for nicotine enough or do we need to consider its forms of…

Psychosocial therapeutic interventions for volatile substance use: a systematic review

ABSTRACT Aims  Volatile substance use (VSU) is associated with a range of adverse outcomes, including cognitive impairment and death. It occurs disproportionately within young and marginalized populations. A previous international systematic review of VSU treatment identified no relevant studies

Commentary on Kelly et al. (2012): Multiple mediation—many mechanisms signal more questions

%excerpt%
Originally posted here:
Commentary on Kelly et al. (2012): Multiple mediation—many mechanisms signal more questions

A longitudinal study of substance use and violent victimization in adulthood among a cohort of urban African Americans

ABSTRACT Aims  This paper examines the effects of experiencing violent victimization in young adulthood on pathways of substance use from adolescence to mid-adulthood. Design  Data come from four assessments of an African American community cohort followed longitudinally from age 6 to 42 years. Setting  The cohort lived in the urban, disadvantaged Woodlawn neighborhood of Chicago in 1966

Commentary on Mehta et al. (2012): Natural history of injecting drug use

%excerpt%
Continued here:
Commentary on Mehta et al. (2012): Natural history of injecting drug use

Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use

%excerpt%
The rest is here:
Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use

100 Years Ago in Addiction Science

%excerpt%
More:
100 Years Ago in Addiction Science

Controlling new drugs under marketing regulations

ABSTRACT Aims  The rapid emergence of myriad substances openly marketed as legal highs’ is straining traditional drug control systems which require time and basic scientific data on harms to react, presenting governments with the dilemma of no response or a disproportionate response. Some countries have side-stepped this using novel policy and legislative approaches. Should other countries consider them

Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence

Abstract Aims: Smokers who lapse during a cessation attempt are at particularly high risk of relapse, so interventions to help smokers recover from lapses are urgently needed. Two recent studies have suggested continuing to use nicotine patches following a lapse may be a beneficial relapse prevention strategy.